GSTZ1 and cancer: Interestingly, DCA, a substrate and mechanism‐based inactivator of GSTZ1‐1 (Tzeng et al, 2000), also reverses the Warburg effect in cancer cells and has been proposed for use in targeted therapy against cancer (Michelakis et al, 2008).